Industry reports
Editor highlights

US Pharmaceutical Sector: Sector Report

Daedal Research
  • Publication date: July 2012
  • Report size: 30 pages
  • Report price: $ 800

Get this report today!

$ 800 - 1 User License
$ 900 - Hard Copy
$ 1 600 - Site License

Summary

Table of Contents

Data Series

This industry profile is an essential tool to help your company gain an in-depth knowledge and competitive advantage in the industry. The profile is an assimilation of insider knowledge, market characteristics and economic indicators. It analyzes the critical success factors in the industry – how the industry has evolved and how competitive dynamics have impacted market behavior.

Sectional Highlights

-- Structure of the industry, market size, and growth rates have been analyzed

-- Value chain analysis categorizes the value-adding activities to develop low-cost differentiation strategies

-- Trend analysis detects historical patterns that could help in forecasting future demand periods

-- Critical issues are reviewed that may become a threat to the industry

-- PEST analysis uses a framework of external factors for macro-environmental scanning of the industry to help in taking advantage of opportunities and making contingency plans for threats

-- Competitive positioning of the industry leaders has been evaluated in terms of sales, profitability, stock trend and other performance indicators

Key Benefits

-- Provides input for strategic business planning

-- Targets business opportunities & risks

-- Exploits competitive intelligence

Target Audience

-- Investment Managers
-- Venture Capitalists
-- Management Consultants
-- Research Companies
-- Other Industry Professionals

Daedal Research
  • Publication date: July 2012
  • Report size: 30 pages
  • Report price: $ 800

Get this report today!

$ 800 - 1 User License
$ 900 - Hard Copy
$ 1 600 - Site License

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

Pharmaceutical Industry in the United States : Latest Reports

PharmaPoint: Microvascular Complications of Diabetes - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Microvascular Complications of Diabetes - Global Drug Forecast and Market Analysis to 2022

  • $ 9 995
  • Industry report
  • December 2013
  • by Global Data

PharmaPoint: Microvascular Complications of Diabetes - Global Drug Forecast and Market Analysis to 2022 Summary The entire market for microvascular complications of diabetes (MCD) - diabetic nephropathy, ...

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022

  • $ 9 995
  • Industry report
  • January 2014
  • by Global Data

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute o ...

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

  • $ 9 995
  • Industry report
  • January 2014
  • by Global Data

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked ...

Global Markets For Generic Drugs

January 2014 $ 6 650

Pharmaceutical Industry in the United States : Latest Downloads

Global Clinical Trial : Innovation and Technology Trends

  • Industry report
  • April 2014
  • 16 pages

... Complexities, and so on). Within the cro market, the largest segment was that of drug discovery. Based on various analyses, the report also anticipates that the market for clinical data management services ...

Drug and Medication Market Brief

  • Industry report
  • March 2014
  • 17 pages

... Hg introduces new recommendations designed to promote safer use of angiotensin converting enzyme inhibitors (aceis) and angiotensin receptor blockers (arbs) first-line and later-line treatment should now ...

Drug Discovery and Development Industry Brief

  • Industry report
  • March 2014
  • 47 pages
  • by Research Paper

... Learn/confirm and predict phase vi registering and labeling (maa) uncertainty confident and drug and disease paediatric strategy & investigation plan scientific advice clinical trial ...


Related Market Segments :

Pharmaceutical Sector

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.